RALEIGH, N.C., Oct. 12, 2016 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, today announced its extensive participation in the Society for Clinical Research Sites' (SCRS) 11th Annual Global Site Solutions Summit Oct. 13-16 in Boca Raton, Fla. INC Research thought leaders will participate in seven sessions to discuss issues that impact the way sites conduct research and recruit patients, while offering strategies to improve collaboration between CROs and sites to more effectively benefit patients.
INC Research will commence its participation with Clare Grace, PhD, Vice President, Site and Patient Access, participating in the summit’s first plenary session, “Sites Matter: Industry Collaboration,” which will explore ongoing transformations affecting sites, including investigator turnover, general public awareness of clinical research, site study dashboards, site payments and standardized contract clauses. On Day 2 of the summit, Dr. Grace will facilitate a Site Solving™ Break-Out Session around solving the clinical trial awareness challenge and share notable highlights from the recent “Inspiring Hope” Ideathon, a crowdsolving event that INC Research and the Center for Information and Study on Clinical Research Participation (CISCRP) co-hosted last month in Boston, which brought together a cross-section of stakeholders across the industry to share and develop innovative ideas for increasing awareness of and participation in clinical trials.
"We are excited to once again be participating in the SCRS Global Site Solutions Summit — an event that consistently has been instrumental in bringing sites, CROs and sponsors together to improve how we all work together in clinical research," said Clare Grace, PhD, Vice President, Site and Patient Access. "The strides we’ve made in recent years to streamline different aspects of the clinical trial process, such as investigator payments, is evidence of this collaboration, but we still have a long way to go. Connecting with sites in such a synergistic environment gives us an opportunity to gain a better understanding of their perspectives and remain mindful of all of the valuable contributions they make in bringing new medicines to market. Without sites, we simply wouldn’t be able to deliver clinical trials.”
INC Research thought leaders will be available throughout the summit at Booth #301 and will participate in the following sessions:
Joining the Catalyst Community
In an effort to strengthen collaborations with clinical research sites worldwide, INC Research is inviting sites to join its Catalyst Community, an online forum designed to support ongoing communication and information exchange on the conduct of clinical trials, wider adoption of new methodologies and evolving best practices. The goal of the community, which is open to all clinical research sites, is to harness the input and insights from sites across the globe in order to develop best practices that increase the quality and predictability of trials and develop continuous site improvements in the delivery of clinical research. Sites interested in becoming part of INC Research’s Catalyst Community can register here or visit Booth #301.
Addressing the investigator payments challenge
INC Research will present new insights from a paper titled “Addressing Pain Points of Investigator Payments for Clinical Trials” at the summit. The paper addresses the challenges surrounding site payments and highlights key insights from the INC Research Site Advocacy Group (SAG) that was established to address such issues and outline initiatives in place to improve the process. The paper can be downloaded here and will be available at INC Research’s booth.
Recognizing sites’ valuable contributions
Following Saturday evening’s Eagle Award™ Gala, INC Research will once again host a Site Appreciation Reception to recognize and celebrate the vital role sites play in the clinical research process. Dr. Grace and INC Research clinical development executives will be available during the reception to meet with investigators and site personnel and discuss effective ways for future collaboration.
INC Research has served as a member of SCRS as well as a Global Impact Partner to the organization since 2014. As a Circle of Innovation Sponsor — the highest level of partnership with SCRS and the only company to sponsor at this level — INC Research has funded more than 500 Site Scholarships that provide the training, mentorship and advocacy that sites need to become members of a world-class clinical research community. INC Research is also actively working with SCRS to strengthen and grow its global membership through the SCRS Ambassador Program, which aims to extend SCRS membership and support to sites globally through regional activity around the world.
About INC Research
INC Research (Nasdaq:INCR) is a leading global contract research organization ("CRO") providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. Leveraging the breadth of our service offerings and the depth of our therapeutic expertise across multiple patient populations, INC Research connects customers, clinical research sites and patients to accelerate the delivery of new medicines to market. The Company was named “Best Contract Research Organization” in December 2015 by an independent panel for Scrip Intelligence, and ranked “Top CRO to Work With” among large global CROs in the 2015 CenterWatch Global Investigative Site Relationship Survey. INC Research is headquartered in Raleigh, NC, with operations across six continents and experience spanning more than 110 countries. For more information, please visit www.incresearch.com and connect with us on LinkedIn and Twitter @inc_research.
Last updated on: 13/10/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.